Outcome of patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors versus cytotoxic chemotherapy
Background: There is no published data on the response and survival of Malaysian patients with locally advanced or metastatic adenocarcinoma of the lung with and without epidermal growth factor receptor (EGFR) mutations treated with EGFRtyrosine kinase inhibitors (TKIs) or cytotoxic chemotherapy. O...
محفوظ في:
المؤلف الرئيسي: | Chai, Chee She |
---|---|
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2015
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://ir.unimas.my/id/eprint/10817/1/Dr%20Chai%20Chee%20Shee%20ft.pdf |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Characteristics of epidermal growth factor receptor (EGFR)-mutated non small cell lung cancer (NSCLC) patients who developed resistance to first-or second-generation egfr-tyrosine kinase inhibitor (TKI) therapy through T790 mutation /
بواسطة: Vijayan Munusamy
منشور في: (2017) -
Regulation of myelomonocytic cell functions by inhibitors of the tyrosine kinase signaling cascade /
بواسطة: Li, Hui
منشور في: (2001) -
Expression of ron tyrosin kinase receptor on breast cancer cell lines
بواسطة: Alzeini, Khaled W. K.
منشور في: (2013) -
Epidermal growth factor receptor (EGFR) mutation in lung carcinoma /
بواسطة: Fatin Izni Nazri
منشور في: (2018) -
Adherence To Tyrosine Kinase Inhibitor Therapy Among Chronic Myeloid Leukemia Patients /
بواسطة: Wilfred, Gilbert
منشور في: (2015)